Abstract

Metabolic Syndrome (MetS) is defined as a clustering of risk factors for diabetes mellitus (T2DM) and cardiovascular disease (CVD) which puts individuals at increased risk of developing these conditions and consequently leads to a reduction in life expectancy and increased morbidity. A systematic review and network meta-analysis was undertaken to assess the relative clinical effectiveness of a number of lifestyle and pharmacological interventions, both independently and in combination. A second systematic review, and series of meta-analyses, was also undertaken to estimate the increased burden that a MetS diagnosis has on the subsequent risk of T2DM, CVD and all-cause mortality. A fully probabilistic economic Markov decision model was developed in WinBUGS, and which directly included the series of meta-analyses above, in order to assess the cost-effectiveness of the various interventions. The use of both lifestyle and pharmacological interventions in combination was dominated in the incremental cost-effectiveness analysis, with the use of both of them independently producing greater health gain at lower cost. Pharmacological intervention was cost-effective compared to standard care (ICER £3050 with a probability of 0.53 at a threshold value of £20K/QALY), and lifestyle intervention was cost-effective compared to pharmacological (ICER £6933 with a probability of 0.52 at a threshold value of £20K/QALY). A series of sensitivity analyses were also undertaken both with regards to the model inputs/distributions and a number of methodological assumptions, but the results remained largely insensitive to these changes. The use of a lifestyle intervention would appear to be a potentially cost-effective treatment strategy for adults with MetS, however considerable uncertainty surrounds this decision. The use of a comprehensive approach to economic modelling within a WinBUGS framework allowed distributional assumptions to be relaxed, sources of correlation to be appropriately accounted for, and more complex sensitivity analyses to be easily undertaken.

Full Text
Paper version not known

Talk to us

Join us for a 30 min session where you can share your feedback and ask us any queries you have

Schedule a call

Disclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.